Baobing Zhao

State Key Laboratory Of Discovery And Utilization Of Functional Components In Traditional Chinese Medicine
Jinan, 250012, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications

Fufang Huangbo Formula mitigates myeloproliferative neoplasms by activating p53/p21 signaling axis and inhibiting STAT3 and NF-κB signaling pathways.

Fufang Huangbo Formula mitigates myeloproliferative neoplasms by activating p53/p21 signaling axis and inhibiting STAT3 and NF-κB signaling pathways.

Journal: Pharmaceutical science advances
Published: January 13, 2026

Thrombopoietin Receptor MPL in Hematopoiesis and Myeloproliferative Neoplasms: Physiological Roles and Pathogenic Mechanisms.

Thrombopoietin Receptor MPL in Hematopoiesis and Myeloproliferative Neoplasms: Physiological Roles and Pathogenic Mechanisms.

Journal: Stem cell reviews and reports
Published: December 02, 2025

Glycolytic-inflammatory crosstalk mediated by Glyco-PMF-Rux hub genes drives PMF progression and ruxolitinib resistance.

Glycolytic-inflammatory crosstalk mediated by Glyco-PMF-Rux hub genes drives PMF progression and ruxolitinib resistance.

Journal: Genes & genomics
Published: November 12, 2025

Integrative transcriptomics defines CD36 as a key regulator of immunometabolic signaling in acute myeloid leukemia.

Integrative transcriptomics defines CD36 as a key regulator of immunometabolic signaling in acute myeloid leukemia.

Journal: Genes & genomics
Published: October 01, 2025

Comprehensive multi-omics analysis of CD36 in pan-cancers: Evaluating role in prognosis, immune microenvironment, and therapeutic response.

Comprehensive multi-omics analysis of CD36 in pan-cancers: Evaluating role in prognosis, immune microenvironment, and therapeutic response.

Journal: Pharmaceutical science advances
Published: September 10, 2025

Physiological MplW514L expression in hematopoietic stem cell causes an essential thrombocythemia and progressive myelofibrosis.

Physiological MplW514L expression in hematopoietic stem cell causes an essential thrombocythemia and progressive myelofibrosis.

Journal: The Journal of clinical investigation
Published: September 02, 2025

Targeting DESI2 as a Novel Therapeutic Strategy for JAK2-Mutant Leukemias.

Targeting DESI2 as a Novel Therapeutic Strategy for JAK2-Mutant Leukemias.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 08, 2025

Inhibition of Pellino-1 reverts the progression and tyrosine kinase inhibitor resistance in chronic myeloid leukemia.

Inhibition of Pellino-1 reverts the progression and tyrosine kinase inhibitor resistance in chronic myeloid leukemia.

Journal: Cell death & disease
Published: August 08, 2025

Mesuaferroic acid H suppresses HepG2 cell proliferation by disrupting iron homeostasis via transferrin targeting.

Mesuaferroic acid H suppresses HepG2 cell proliferation by disrupting iron homeostasis via transferrin targeting.

Journal: Bioorganic chemistry
Published: June 24, 2025

Neuroprotective Effects of Rhamnosyl Icariside II in 6-OHDA-Treated PC12 Cells and Zebrafish.

Neuroprotective Effects of Rhamnosyl Icariside II in 6-OHDA-Treated PC12 Cells and Zebrafish.

Journal: Molecular neurobiology
Published: May 14, 2025

Clonal hematopoiesis of indeterminate potential: recent developments and perspectives.

Clonal hematopoiesis of indeterminate potential: recent developments and perspectives.

Journal: Current opinion in hematology
Published: March 10, 2025

Pleckstrin-2 promotes the progression of colorectal cancer via YTHDF2-mediated TYMS mRNA stability.

Pleckstrin-2 promotes the progression of colorectal cancer via YTHDF2-mediated TYMS mRNA stability.

Journal: Cellular and molecular life sciences : CMLS
Published: January 22, 2025
Showing 1-12 of 55

Last Updated: 09/26/2026